Skip to main content

Pharmacokinetics and organ distribution of diarylheptanoid phytoestrogens from Curcuma comosa in rats


Curcuma comosa is widely used as a traditional herbal medicine for gynecological diseases in South East Asia. Previous studies reported that it has phytoestrogenic activity, and several diarylheptanoids were found to be the active constituents. In this study, the pharmacokinetics profile and organ distribution of three active compounds of C. comosa hexane extract were investigated. Rats were separately administered C. comosa hexane extract intravenously at the dose of 125 mg/kg and orally at the doses of 125 and 250 mg/kg body weight, after which blood and target organs were collected at specified time intervals from 0 to 24 h. HPLC was used to measure the concentration of three major compounds, (6E)-1,7-diphenylhept-6-en-3-one (DPH1), (4E,6E)-1,7-diphenylhepta-4,6-dien-3-ol (DPH2), and (6E)-1,7-diphenylhept-6-en-3-ol (DPH3), which were found to be present in the blood and tissues and were subsequently used as markers. In the intravenous study, the volumes of distribution (V d) were 1.06, 8.57, and 6.56 L/kg and clearance values (CLs) were 0.28, 5.56, and 3.39 L/kg/h for DPH1, DPH2, and DPH3, respectively. After oral administration, the three major compounds of both doses reached a maximum systemic concentration at 2 h with maximum concentration (C max) of 0.85, 0.17, and 0.53 mg/L for the lower dose and 1.46, 0.17, and 0.61 mg/L for the higher dose. The bioavailabilities were 31.2, 24.01, and 31.56% for lower dose and 22.61, 17.66, and 17.73% for higher dose with a terminal half-life (t 1/2) of 10.86, 6.3, and 4.62 h for lower dose and 3.85, 2.77, and 2.10 h for higher dose for DPH1, DPH2, and DPH3, respectively. These three major compounds are all found distributed in the brain, liver, kidneys, ovaries, and uterus after oral and intravenous administration and their related pharmacokinetic parameters are described. This study provides the essential pharmacokinetic data for diarylheptanoid phytoestrogenic compounds of C. comosa extract which are required for clinical dose and dosage design.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5









Central nervous system

CLs :


V d :

Volume of distribution

t 1/2 :

Terminal half-life

C max :

Maximum concentration

t max :

Time to reach the maximum concentration


Area under the curve


Mean resident time


  1. 1.

    Kris-Etherton PM, Hecker KD, Bonanome A, Coval SM, Binkoski AE, Hilpert KF et al (2002) Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. Am J Med 113(9B):71–88

    Article  Google Scholar 

  2. 2.

    Goldwyn S, Lazinsky A, Wei H (2000) Promotion of health by soy isoflavones: efficacy, benefit and safety concerns. Drug Metabol Drug Interact 17:261–289

    PubMed  Article  CAS  Google Scholar 

  3. 3.

    Wiseman H (2000) The therapeutic potential of phytoestrogens. Expert Opin Investig Drugs 9:1829–1840

    PubMed  Article  CAS  Google Scholar 

  4. 4.

    Adlercreutz H (1998) Epidemiology of phytoestrogens. Baillieres Clin Endocrinol Metab 12:605–623

    PubMed  Article  CAS  Google Scholar 

  5. 5.

    Piyachaturawat P, Ercharuporn S, Suksamrarn A (1995) Estrogenic activity of Curcuma comosa extract in rats. Asia Pacific J Pharmacol 10:121–126

    Google Scholar 

  6. 6.

    Piyachaturawat P, Ercharuporn S, Suksamrarn A (1995) Uterotrophic effect of Curcuma comosa in rats. Inter J Pharmacog 33:334–338

    Article  Google Scholar 

  7. 7.

    Suksamrarn A, Ponglikitmongkol M, Wongkrajang K, Chindaduang A, Kittidanairak S, Jankam A et al (2008) Diarylheptanoids, new phytoestrogens from the rhizomes of Curcuma comosa: isolation, chemical modification and estrogenic activity evaluation. Bioorg Med Chem 16:6891–6902

    PubMed  Article  CAS  Google Scholar 

  8. 8.

    Jantaratnotai N, Utaisincharoen P, Piyachaturawat P, Chongthammakun S, Sanvarinda Y (2006) Inhibitory effect of Curcuma comosa on NO production and cytokine expression in LPS-activated microglia. Life Sci 78:571–577

    PubMed  Article  CAS  Google Scholar 

  9. 9.

    Sodsai A, Piyachaturawat P, Sopasan S, Suksamran A, Vongskul M (2007) Suppression by Curcuma comosa Roxb. of pro-inflammatory cytokine secretion in phorbol-12-myristate-13-acetate stimulated human mononuclear cells. Inter Immunopharmacol 7:524–531

    Article  CAS  Google Scholar 

  10. 10.

    Piyachaturawat P, Chai-ngam N, Chuncharunee A, Komaratat P, Suksamrarn A (2000) Choleretic activity of phloracetophenone in rats: structure–function studies using acetophenone analogues. Eur J Pharmacol 387:221–227

    PubMed  Article  CAS  Google Scholar 

  11. 11.

    Piyachaturawat P, Gansar R, Suksamrarn A (1996) Choleretic effect of Curcuma somosa rhizome extracts in rats. Inter J Pharmacog 34:174–178

    Article  Google Scholar 

  12. 12.

    Piyachaturawat P, Teeratagolpisal N, Toskulkao C, Suksamrarn A (1997) Hypolipidemic effect of Curcuma comosa in mice. Artery 22:233–241

    PubMed  CAS  Google Scholar 

  13. 13.

    Piyachaturawat P, Charoenpiboonsin J, Toskulkao C, Suksamrarn A (1999) Reduction of plasma cholesterol by Curcuma comosa extract in hypercholesterolaemic hamsters. J Ethnopharmacol 66:199–1204

    PubMed  Article  CAS  Google Scholar 

  14. 14.

    Su J, Sripanidkulchai K, Wyss JM, Sripanidkulchai B (2010) Curcuma comosa improves learning and memory function on ovariectomized rats in a long-term Morris water maze test. J Ethnopharmacol 130:70–75

    PubMed  Article  Google Scholar 

  15. 15.

    Su J, Sripanidkulchai B, Sripanidkulchai K, Piyachaturawat P, Wara-Aswapati N (2010) Effect of Curcuma comosa and estradiol on the spatial memory and hippocampal estrogen receptor in the post-training ovariectomized rats. J Nat Med 65:57–62

    PubMed  Article  Google Scholar 

  16. 16.

    Kwon Y (2001) Handbook of essential pharmacokinetics, pharmacodynamics and drug metabolism for industrial scientists, 1st edn. Springer, San Diego

    Google Scholar 

  17. 17.

    Setchell KD (2000) Absorption and metabolism of soy isoflavones-from food to dietary supplements and adults to infants. J Nutr 130:654S–655S

    PubMed  CAS  Google Scholar 

  18. 18.

    Kwon SH, Kang MJ, Huh JS, Ha KW, Lee JR, Lee SK et al (2007) Comparison of oral bioavailability of genistein and genistein in rats. Int J Pharm 337:148–154

    PubMed  Article  CAS  Google Scholar 

  19. 19.

    Zhou S, Hu Y, Zhang B, Teng Z, Gan H, Yang Z et al (2008) Dose-dependent absorption, metabolism, and excretion of genistein in rats. J Agric Food Chem 56:8354–8359

    PubMed  Article  CAS  Google Scholar 

Download references


This study was funded by the National Research Council of Thailand and the Center for Research and Development of Herbal Health Products, Khon Kaen University, Thailand. The authors would like to thank Dr. Aporanee Chiayakum for her advice in the pharmacokinetic data interpretation.

Author information



Corresponding author

Correspondence to Bungorn Sripanidkulchai.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Su, J., Sripanidkulchai, K., Suksamrarn, A. et al. Pharmacokinetics and organ distribution of diarylheptanoid phytoestrogens from Curcuma comosa in rats. J Nat Med 66, 468–475 (2012).

Download citation


  • Curcuma comosa
  • Phytoestrogen
  • Diarylheptanoids
  • Organ distribution
  • Pharmacokinetics
  • HPLC
  • Bioavailability